Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v2-FR
Language English French
Date Updated 2022-05-25 2022-02-03
Drug Identification Number 00559253 00559253
Brand name PROSTIN VR STERILE SOLUTION PROSTIN VR STERILE SOLUTION
Common or Proper name PROSTIN VR STERILE SOLUTION PROSTIN VR STERILE SOLUTION
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ALPROSTADIL ALPROSTADIL
Strength(s) 500MCG 500MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRA-ARTERIAL INTRAVENOUS INTRA-ARTERIAL INTRAVENOUS INTRA-ARTERIAL INTRAVENOUS INTRA-ARTERIAL
Packaging size 5 x1mL amp 5 x1mL amp
ATC code C01EA C01EA
ATC description OTHER CARDIAC PREPARATIONS OTHER CARDIAC PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-02-02 2022-02-02
Estimated end date 2022-04-29
Actual end date 2022-05-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Inventory is on preventative allocation.
Health Canada comments